VIAV Stock Rises 430.7% in a Year: How to Play the Stock

Viavi shares have surged 430.7% over the past year, outpacing the industry’s 350.7% gain, as AI data center spending and aerospace/defense demand drive growth. Q1 FY26 operating cash flow was $31 million and free cash flow was $22.5 million, while RPO stood at $352.6 million with about 91% expected to convert within 12 months. Management also said the Spirent acquisition should contribute about $200 million in annual revenue, above the prior $188 million estimate, and earnings estimates for 2026 and 2027 have improved.

Analysis

VIAV is increasingly functioning as a leveraged AI-infrastructure toll collector rather than a pure test-equipment cyclicals name. The important second-order effect is that its growth is being pulled by two distinct capex waves — hyperscale scale-up/scale-out interconnect and defense timing/navigation — which reduces single-end-market dependence and gives it a longer earnings runway than most peers. That mix also makes the stock more resilient to a temporary pause in one vertical, because the backlog and conversion profile can keep revenue compounding even if new orders slow for a quarter.

The bigger competitive implication is that VIAV’s Spirent assets may be more strategically important than the headline revenue contribution suggests. If it is gaining share in high-speed Ethernet testing, the real prize is design-win adjacency: once embedded in validation workflows, switching costs rise and attach rates improve across later-generation AI networking transitions. That can pressure KEYS and TER indirectly, but the longer-term loser could be smaller niche test vendors and network-security point solutions that rely on fragmented budgets rather than platform breadth.

The market is likely underappreciating valuation compression risk if the recent move has already priced in a lot of the 2026 growth. At roughly 40x forward earnings, the stock is not cheap for a business still exposed to customer capex timing, integration execution, and the possibility that AI networking spend normalizes after the current buildout phase. The catalyst path is mostly months, not days: continued estimate revisions, a clean integration readout, and evidence that backlog converts without margin dilution.

Contrarianly, the consensus may be too focused on the AI label and not enough on whether VIAV’s growth is becoming more durable than the multiple implies. If this is really a multi-year share-gain story in testing, the current premium to some industrial tech names may still be justified; if not, the stock becomes vulnerable to any disappointment in 2H26 guidance. The asymmetry is now about execution quality, not demand existence.

Key Decisions for Investors

• Stay long VIAV, but treat it as a 6-12 month execution trade rather than a momentum chase; add only on post-earnings pullbacks if management reiterates 2026 growth and backlog conversion, targeting another 15-20% upside with ~10% downside if guidance holds.
• Pair trade: long VIAV / short KEYS for a relative-share-gain thesis in AI-network validation and high-speed Ethernet testing over the next 2-3 quarters; best setup if VIAV continues estimate revisions while KEYS remains more cyclical.
• Use VIAV January 2026 call spreads instead of outright stock for a cleaner risk/reward on backlog-to-revenue conversion; structure for upside into the next two earnings prints while capping premium paid if integration stalls.
• Avoid chasing CIEN strength as a direct comp; if anything, monitor for VIAV/CIEN mean reversion only on evidence that VIAV’s Spirent integration underdelivers or backlog conversion slows.
• Hedge the long with a small short TER basket if AI test spend is the common denominator you want to isolate; this reduces beta to broader semiconductor test demand while keeping exposure to the networking-validation winner.